Relationship between nonmotor symptoms and neutrophil-to-lymphocyte ratio in Parkinson’s disease
Öz
Purpose: The aim of this study was to investigate the relationship between neutrophil-to-lymphocyte ratio (NLR), an inflammation marker, and nonmotor symptoms, such as fatigue, sleep disturbances, and overall quality of life, in Parkinson’s disease (PD).
Materials and Methods: This study included 60 patients diagnosed with PD (17 female and 43 male). Fatigue was assessed using the Parkinson’s Disease Fatigue Scale (PFS-16), sleep quality using the Parkinson’s Disease Sleep Scale (PDSS), and quality of life using the Parkinson’s Disease Questionnaire-8 (PDQ-8). Neutrophil and lymphocyte counts were extracted from the complete blood count results, and the NLR was calculated.
Results: A moderate, negative correlation was observed between fatigue and sleep quality; a moderate, positive correlation was observed between quality of life, motor rating, and disease staging; a moderate, negative correlation was observed between sleep quality and quality of life; a weak, negative correlation was observed between sleep quality, motor rating, and disease staging; and a weak, positive correlation was found between quality of life, motor rating, and disease staging. No significant relationship was observed between NLR and nonmotor symptoms in PD.
Conclusion: Further prospective studies with larger samples or case–control designs are warranted to explore the potential clinical utility of a simple, cost-effective biomarker, such as NLR, in assessing PD symptoms and disease progression.
Anahtar Kelimeler
Parkinson’s Disease, fatigue, sleep disorders, quality of life, neutrophil-to-lymphocyte ratio.
Destekleyen Kurum
yok
Proje Numarası
Clinicaltrials: NCT05687799
Etik Beyan
Niğde Ömer Halisdemir University Faculty of Medicine Non-Interventional Clinical Research Ethics Committee approval has been granted from our institution with protocol number Meeting/Decision No: 2022-107
Kaynakça
- Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm. 2017;124:901-5.
- Alexander GE. Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci. 2004;6:259-80.
- X- Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system-associations, mechanisms and therapeutics. Nat Rev Neurol. 2020;16:303-318.
- Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord. 2006;21:916-23.
- Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG. Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's. Parkinsonism Relat Disord. 2019;64:220-225.
- Wang H, Liu Y, Zhao J, Guo X, Hu M, Chen Y. Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review). Clin Neurol Neurosurg. 2021;208:106844.
- Borsche M, König IR, Delcambre S, Petrucci S, Balck A, Brüggemann N et al. Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism. Brain. 2020;143:3041-3051.
- Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021;7:27.
- Fischer R, Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev. 2015;610813.
- Amor S, Puentes F, Baker D, Van der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129:154-69.
